Rinvoq ER 30 MG tablet UU 30S
Ended Awarded
- Contract number
- SPE2DB26FX4CU
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $93,354
Award facts
- Contract value 100% obligated
- $93,353.63 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 30, 2025, for the supply of RINVOQ ER 30 mg tablets (30-count units) valued at $93,353.63. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by October 31, 2025, and will be performed at AmerisourceBergen's corporate headquarters in Conshohocken, Pennsylvania. RINVOQ is a prescription immunosuppressant medication used primarily in the treatment of rheumatoid arthritis and other inflammatory conditions, representing the type of specialty pharmaceutical products that support federal healthcare needs.
This delivery order is a child contract issued under AmerisourceBergen Drug Corp's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. As a major pharmaceutical distributor and healthcare solutions provider, AmerisourceBergen serves as a critical vendor for military and veteran healthcare systems through the Defense Logistics Agency's Medical Supply Chain. The company's extensive federal contract portfolio demonstrates consistent capability to deliver brand-name and generic medications, vaccines, and specialized medical supplies across multiple therapeutic domains to support Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems worldwide.
Quick answers
Who was awarded contract SPE2DB26FX4CU?
SPE2DB26FX4CU was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on October 30, 2025.
How much is contract SPE2DB26FX4CU worth?
The government has obligated $93,354 on SPE2DB26FX4CU.
Is contract SPE2DB26FX4CU an order under another contract?
Yes. SPE2DB26FX4CU is a delivery order under SPE2DB22D3301, an indefinite delivery contract.
Was contract SPE2DB26FX4CU competed?
The extent of competition for SPE2DB26FX4CU was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award